Strong investment: Octapharma opens up new production facility in Austria

Strong investment: Octapharma opens up new production facility in Austria

Laimgrubengasse 10, 1060 Wien, Österreich - On December 18, 2024, Octapharma opened a new production facility in Austria, which was built with an investment of 200 million euros. This strong commitment to Austria's pharmaceutical location underlines the importance of the company at a global level. Mag. Alexander Herzog, General Secretary of the Pharmig, emphasizes that every investment creates jobs and increases value creation. It is particularly noteworthy that the new system will make a decisive contribution to supplying people worldwide with life -saving medicines on blood plaspasis. Despite these positive developments, Herzog warns of the challenges with which pharmaceutical companies are confronted. The restrictive price regulations and the increasing inflation represent considerable loads that should not remain uncommented.

criticism of the framework conditions

Duke emphasizes that the regulatory requirements and the legally regulated prices for reimbursable medication are increasingly difficult. "The companies cannot simply compensate for increasing costs through price increases, as is common in other industries," explains Herzog. This can cause products to be taken from the market - a development that already means that around 20 medication every month. In order to counteract this trend, the Pharmig calls for inflation adjustment for drug prices to ensure security of supply in Austria in the long term.

Octapharma, an international family company with headquarters in Switzerland, is one of the largest producers of human protein worldwide and operates several research and development centers in Europe, including Austria. Your products are available in 118 markets and new employees are added every year to improve the quality of life of patients. With six modern production facilities in Austria and other countries, Octapharma plays a central role in pharmaceutical supply and thus ensures that innovative solutions and medication can continue to be provided in the future, as can be experienced on the Octopharma website.